Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study
To collect and analyze specimens that will correlate with clinical outcomes such as acute and late toxicities, quality of life, local control, and survival of patients treated with photon/proton therapy.
Conditions:
🦠 Solid Tumors 🦠 Hematologic Malignancies
🗓️ Study Start (Actual) April 2015
🗓️ Primary Completion (Estimated) April 2025
✅ Study Completion (Estimated) April 2025
👥 Enrollment (Estimated) 15000
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Rochester, Minnesota, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • 1. Treated with photon/proton at Mayo Clinic Rochester in Radiation Oncology
    • 2. Radiation therapy for curative intent

    Exclusion Criteria:

    • None
Ages Eligible for Study: N/A to N/A (CHILD, ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 11 May 2015
  • First Submitted that Met QC Criteria 27 May 2015
  • First Posted 29 May 2015

Study Record Updates

  • Last Update Submitted that Met QC Criteria 12 July 2023
  • Last Update Posted 13 July 2023
  • Last Verified July 2023